Tag: novo nordisk

April 17, 2020

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
November 1, 2018

Strongbridge Biopharma Share Price Spikes 58 Percent

What likely triggered this share price increase was the company announcing a deal with Novo Nordisk, along with releasing its...
October 31, 2018

Strongbridge Biopharma Enters into Agreement for Novo Nordisk

Strongbridge Biopharma (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with...
February 9, 2018

Novo Nordisk Ozempic approved in the EU for the treatment of type 2 diabetes

Novo Nordisk (CPH:NOVO-B) announced that the European Commission (EC) has granted marketing authorisation for Ozempic® (semaglutide) for the treatment of adults...
February 8, 2018

Everthing You Need to Know About the Longevity Thematic ETF

In the last year, LNGR has given investors a 23.67 percent return, and is expected to increase by 29.38 percent...
December 20, 2017

Pharma Trends 2017: FDA Pushes Creation of More Generic Drugs

INN takes a look at some of the major stories and developments in the pharma industry during 2017.
December 5, 2016

Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes

Novo Nordisk today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for semaglutide,...